Tivity Health, Inc. Common Stock
TVTY
TVTY was delisted on the 27th of June, 2022.
4 hedge funds and large institutions have $703K invested in Tivity Health, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 168 closing their positions.
98% less funds holding
Funds holding: 177 → 4 (-173)
100% less capital invested
Capital invested by funds: $1.43B → $703K (-$1.42B)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 168
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$232M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$157M |
| 3 |
HVCM
HG Vora Capital Management
New York
|
-$154M |
| 4 |
HEC
Hudson Executive Capital
New York
|
-$154M |
| 5 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$92.7M |
TVTY Hedge Fund Activity: Q2 2022 in Review
4 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Tivity Health, Inc. Common Stock (TVTY) for Q2 2022, worth a combined $703K — down 100% from $1.43B a quarter earlier.
Sellers outnumbered buyers: 168 funds closed out of TVTY and 0 opened new positions — a net loss of 168 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $232M sold.
- 4 institutional investors held Tivity Health, Inc. Common Stock (TVTY) as of Q2 2022, down from 177 in Q1 2022.
- Funds reported $703K of Tivity Health, Inc. Common Stock stock for Q2 2022, down 100% quarter-over-quarter.
- 0 funds opened new Tivity Health, Inc. Common Stock positions in Q2 2022 and 168 closed out, a net change of -168 holders.
- The largest Tivity Health, Inc. Common Stock seller in Q2 2022 was BlackRock, an estimated $232M sold.
Based on aggregated 13F filings for Q2 2022.